Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

812.69
+7.260.90%
Post-market: 811.55-1.1400-0.14%19:59 EDT
Volume:2.98M
Turnover:2.41B
Market Cap:770.22B
PE:66.13
High:815.19
Open:809.00
Low:802.37
Close:805.43
Loading ...

Eli Lilly (LLY) Gains CHMP Approval for Donanemab in Alzheimer's Treatment

Simply Wall St.
·
6 hours ago

Eli Lilly, McDonald’s, Marvell, Delta, RTX: Insider Sales Shake Market

TIPRANKS
·
Yesterday

Major Shift: Lilly Endowment Inc Sells Massive Eli Lilly & Co Stock

TIPRANKS
·
Yesterday

Eli Lilly's Director Lilly Endowment Inc. sold 279,000 Shares.

Filings Track
·
Yesterday

Lilly Endowment Inc Reports Disposal of Common Shares of Eli Lilly and Company

Reuters
·
Yesterday

Europe Grants Limited Approval to Eli Lilly’s (LLY) Alzheimer’s Drug

TIPRANKS
·
Yesterday

Eli Lilly’s Promising Study on Weight Management in Type 2 Diabetes

TIPRANKS
·
Yesterday

Eli Lilly and Loxo Oncology’s Promising Phase 3 CLL/SLL Study Update

TIPRANKS
·
Yesterday

Eli Lilly’s LY3971297 Study: A Potential Game-Changer for Obesity and Hypertension

TIPRANKS
·
Yesterday

Eli Lilly Shares up 1% After EU Regulator Recommends Approval for Its Alzheimer's Drug

THOMSON REUTERS
·
25 Jul

Eli Lilly Completes Acquisition of Verve Therapeutics

MT Newswires Live
·
25 Jul

BRIEF-Donanemab Receives Positive Opinion From The Committee For Medicinal Products For Human Use

Reuters
·
25 Jul

Eli Lilly's Donanemab Receives Positive CHMP Opinion for Early Alzheimer's Treatment, Awaits European Commission's Final Decision

Reuters
·
25 Jul

Donanemab Receives Positive Opinion From the Committee for Medicinal Products for Human Use (Chmp) in Early Symptomatic Alzheimer's Disease

THOMSON REUTERS
·
25 Jul

Exclusive-China's Sciwind in Talks to License Weight-Loss Drug in US, CEO Says

THOMSON REUTERS
·
25 Jul

Form 144 | ELI LILLY's Officer Diane M.Stenson proposes to sell 280,000 Shares, with a total value of approximately $224 Million.

Filings Track
·
25 Jul

Eli Lilly’s LOXO-783 Study: A Potential Game-Changer in Cancer Treatment

TIPRANKS
·
25 Jul

The 3 Things That Matter for Eli Lilly Now

Motley Fool
·
24 Jul

Eli Lilly and Company to Announce Second-Quarter 2025 Financial Results

Reuters
·
24 Jul

Eli Lilly Completes Tender Offer for Verve Therapeutics Shares

MT Newswires Live
·
24 Jul